|
| 36260109 | The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy. | Strahlenther Onkol | 2023 |
| 37277265 | Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419). | Eur J Cancer | 2023 |
| 34672349 | Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG). | Neuro Oncol | 2022 |
| 35626167 | MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. | Cancers (Basel) | 2022 |
| 36112492 | Does increase of symptoms mean progression? | Neuro Oncol | 2022 |
| 35315594 | The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies. | Cancer Med | 2022 |
| 35213082 | Prognostic impact of genetic alterations and methylation classes in meningioma. | Brain Pathol | 2022 |
| 35331339 | DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients. | Acta Neuropathol Commun | 2022 |
| 35326730 | MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy. | Cancers (Basel) | 2022 |
| 33956203 | Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma. | Cancer Immunol Immunother | 2021 |
| 33660386 | Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study. | Oncologist | 2021 |
| 33688378 | Elderly patients with cancer. | Memo | 2021 |
| 34514510 | Will mastering ferroptosis allow treating refractory meningiomas? | Neuro Oncol | 2021 |
| 30328719 | Cancer rehabilitation: current trends and practices within an Austrian University Hospital Center. | Disabil Rehabil | 2020 |
| 31969991 | Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors. | NPJ Vaccines | 2020 |
| 33110138 | Distributed changes of the functional connectome in patients with glioblastoma. | Sci Rep | 2020 |
| 33051192 | Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field. | ESMO Open | 2020 |
| 33184096 | Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours. | ESMO Open | 2020 |
| 32831157 | Analysis of the inflammatory tumor microenvironment in meningeal neoplasms. | Clin Neuropathol | 2020 |
| 32603949 | Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer. | Eur J Cancer | 2020 |
| 32678971 | Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases. | Cancer | 2020 |
| 32651730 | Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment. | Curr Oncol Rep | 2020 |
| 33010094 | Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study. | Oncologist | 2020 |
| 32424065 | Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma. | ESMO Open | 2020 |
| 32342331 | Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma. | J Neurooncol | 2020 |
| 31525325 | Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death. | Transl Res | 2020 |
| 30389240 | Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma. | Radiother Oncol | 2019 |
| 31847343 | Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma. | Cancers (Basel) | 2019 |
| 31661065 | Multicentric malignant glioma with striking morphologic heterogeneity and early and extensive metastatic spread to the bone. | Clin Neuropathol | 2019 |
| 31882734 | Applied Precision Cancer Medicine in Neuro-Oncology. | Sci Rep | 2019 |
| 31463975 | GDF-15 in solid vs non-solid treatment-naïve malignancies. | Eur J Clin Invest | 2019 |
| 31423337 | Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI. | ESMO Open | 2019 |
| 31099477 | Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer. | J Thromb Haemost | 2019 |
| 30968400 | Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer. | Br J Haematol | 2019 |
| 30994047 | Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study. | Acta Oncol | 2019 |
| 29368212 | The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033. | Acta Neuropathol | 2018 |
| 30150718 | The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. | Nat Med | 2018 |
| 30062604 | The prognostic value of [<sup>123</sup>I]-vascular endothelial growth factor ([<sup>123</sup>I]-VEGF) in glioma. | Eur J Nucl Med Mol Imaging | 2018 |
| 30296815 | Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer. | Thromb Haemost | 2018 |
| 30518425 | Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. | Acta Neuropathol Commun | 2018 |
| 30301187 | Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial. | Cancers (Basel) | 2018 |
| 29676036 | Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism. | J Thromb Haemost | 2018 |
| 29487022 | Methylation of PD-1 Promoter Gene as New Prognostic Marker for IDH Mutant Low-Grade Glioma? | EBioMedicine | 2018 |
| 29788480 | How should adult patients with neurofibromatosis 1 be managed? | Neuro Oncol | 2018 |
| 27300198 | Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status. | Eur Radiol | 2017 |
| 28483413 | European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. | Lancet Oncol | 2017 |
| 28106065 | Neuro-oncology in 2016: Advances in brain tumour classification and therapy. | Nat Rev Neurol | 2017 |
| 28391295 | Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). | Neuro Oncol | 2017 |
| 28367251 | Milestones of the last 10Â years: CNS cancer. | Memo | 2017 |
| 28987193 | Brain tumors - other treatment modalities. | Handb Clin Neurol | 2017 |